2018-2023 Global Rare Disease Treatment Market Report (Status and Outlook)

October 2018 | 139 pages | ID: 2BD8A026A18EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Rare Disease Treatment market for 2018-2023.
A rare disease is any disease that affects a small percentage of the population.
Most rare diseases are genetic and thus are present throughout the person's entire life, even if symptoms do not immediately appear.

Over the next five years, LPI(LP Information) projects that Rare Disease Treatment will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Rare Disease Treatment market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Originator Drugs
• Generic Drugs

Segmentation by application:

• Hospital Pharmacies
• Specialty Pharmacies
• Retail Pharmacies

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Novartis
• Pfizer
• F. Hoffmann-La Roche
• Celgene
• AbbVie
• Johnson & Johnson
• Shire
• Alexion
• Novo Nordisk
• Sanofi
• Bayer
• Amgen
• Allergan
• Eisai
• Bristol-Myers Squibb
• Merck
• Vertex Pharmaceuticals
• Baxter
• BioMarin
• Teva Pharmaceutical Industries

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global Rare Disease Treatment market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Rare Disease Treatment market by identifying its various subsegments.
• Focuses on the key global Rare Disease Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Rare Disease Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Rare Disease Treatment submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2018-2023 GLOBAL RARE DISEASE TREATMENT MARKET REPORT (STATUS AND OUTLOOK)

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Rare Disease Treatment Market Size 2013-2023
  2.1.2 Rare Disease Treatment Market Size CAGR by Region
2.2 Rare Disease Treatment Segment by Type
  2.2.1 Originator Drugs
  2.2.2 Generic Drugs
2.3 Rare Disease Treatment Market Size by Type
  2.3.1 Global Rare Disease Treatment Market Size Market Share by Type (2013-2018)
  2.3.2 Global Rare Disease Treatment Market Size Growth Rate by Type (2013-2018)
2.4 Rare Disease Treatment Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Specialty Pharmacies
  2.4.3 Retail Pharmacies
2.5 Rare Disease Treatment Market Size by Application
  2.5.1 Global Rare Disease Treatment Market Size Market Share by Application (2013-2018)
  2.5.2 Global Rare Disease Treatment Market Size Growth Rate by Application (2013-2018)

3 GLOBAL RARE DISEASE TREATMENT BY PLAYERS

3.1 Global Rare Disease Treatment Market Size Market Share by Players
  3.1.1 Global Rare Disease Treatment Market Size by Players (2016-2018)
  3.1.2 Global Rare Disease Treatment Market Size Market Share by Players (2016-2018)
3.2 Global Rare Disease Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RARE DISEASE TREATMENT BY REGIONS

4.1 Rare Disease Treatment Market Size by Regions
4.2 Americas Rare Disease Treatment Market Size Growth
4.3 APAC Rare Disease Treatment Market Size Growth
4.4 Europe Rare Disease Treatment Market Size Growth
4.5 Middle East & Africa Rare Disease Treatment Market Size Growth

5 AMERICAS

5.1 Americas Rare Disease Treatment Market Size by Countries
5.2 Americas Rare Disease Treatment Market Size by Type
5.3 Americas Rare Disease Treatment Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Rare Disease Treatment Market Size by Countries
6.2 APAC Rare Disease Treatment Market Size by Type
6.3 APAC Rare Disease Treatment Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Rare Disease Treatment by Countries
7.2 Europe Rare Disease Treatment Market Size by Type
7.3 Europe Rare Disease Treatment Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Rare Disease Treatment by Countries
8.2 Middle East & Africa Rare Disease Treatment Market Size by Type
8.3 Middle East & Africa Rare Disease Treatment Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL RARE DISEASE TREATMENT MARKET FORECAST

10.1 Global Rare Disease Treatment Market Size Forecast (2018-2023)
10.2 Global Rare Disease Treatment Forecast by Regions
  10.2.1 Global Rare Disease Treatment Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Rare Disease Treatment Forecast by Type
10.8 Global Rare Disease Treatment Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Novartis
  11.1.1 Company Details
  11.1.2 Rare Disease Treatment Product Offered
  11.1.3 Novartis Rare Disease Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Novartis News
11.2 Pfizer
  11.2.1 Company Details
  11.2.2 Rare Disease Treatment Product Offered
  11.2.3 Pfizer Rare Disease Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Pfizer News
11.3 F. Hoffmann-La Roche
  11.3.1 Company Details
  11.3.2 Rare Disease Treatment Product Offered
  11.3.3 F. Hoffmann-La Roche Rare Disease Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 F. Hoffmann-La Roche News
11.4 Celgene
  11.4.1 Company Details
  11.4.2 Rare Disease Treatment Product Offered
  11.4.3 Celgene Rare Disease Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Celgene News
11.5 AbbVie
  11.5.1 Company Details
  11.5.2 Rare Disease Treatment Product Offered
  11.5.3 AbbVie Rare Disease Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 AbbVie News
11.6 Johnson & Johnson
  11.6.1 Company Details
  11.6.2 Rare Disease Treatment Product Offered
  11.6.3 Johnson & Johnson Rare Disease Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Johnson & Johnson News
11.7 Shire
  11.7.1 Company Details
  11.7.2 Rare Disease Treatment Product Offered
  11.7.3 Shire Rare Disease Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Shire News
11.8 Alexion
  11.8.1 Company Details
  11.8.2 Rare Disease Treatment Product Offered
  11.8.3 Alexion Rare Disease Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 Alexion News
11.9 Novo Nordisk
  11.9.1 Company Details
  11.9.2 Rare Disease Treatment Product Offered
  11.9.3 Novo Nordisk Rare Disease Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.9.4 Main Business Overview
  11.9.5 Novo Nordisk News
11.10 Sanofi
  11.10.1 Company Details
  11.10.2 Rare Disease Treatment Product Offered
  11.10.3 Sanofi Rare Disease Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.10.4 Main Business Overview
  11.10.5 Sanofi News
11.11 Bayer
11.12 Amgen
11.13 Allergan
11.14 Eisai
11.15 Bristol-Myers Squibb
11.16 Merck
11.17 Vertex Pharmaceuticals
11.18 Baxter
11.19 BioMarin
11.20 Teva Pharmaceutical Industries

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Rare Disease Treatment
Figure Rare Disease Treatment Report Years Considered
Figure Market Research Methodology
Figure Global Rare Disease Treatment Market Size Growth Rate 2013-2023 ($ Millions)
Table Rare Disease Treatment Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Originator Drugs
Table Major Players of Generic Drugs
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Rare Disease Treatment Market Size Market Share by Type (2013-2018)
Figure Global Rare Disease Treatment Market Size Market Share by Type (2013-2018)
Figure Global Originator Drugs Market Size Growth Rate
Figure Global Generic Drugs Market Size Growth Rate
Figure Rare Disease Treatment Consumed in Hospital Pharmacies
Figure Global Rare Disease Treatment Market: Hospital Pharmacies (2013-2018) ($ Millions)
Figure Global Hospital Pharmacies YoY Growth ($ Millions)
Figure Rare Disease Treatment Consumed in Specialty Pharmacies
Figure Global Rare Disease Treatment Market: Specialty Pharmacies (2013-2018) ($ Millions)
Figure Global Specialty Pharmacies YoY Growth ($ Millions)
Figure Rare Disease Treatment Consumed in Retail Pharmacies
Figure Global Rare Disease Treatment Market: Retail Pharmacies (2013-2018) ($ Millions)
Figure Global Retail Pharmacies YoY Growth ($ Millions)
Table Global Rare Disease Treatment Market Size by Application (2013-2018) ($ Millions)
Table Global Rare Disease Treatment Market Size Market Share by Application (2013-2018)
Figure Global Rare Disease Treatment Market Size Market Share by Application (2013-2018)
Figure Global Rare Disease Treatment Market Size in Hospital Pharmacies Growth Rate
Figure Global Rare Disease Treatment Market Size in Specialty Pharmacies Growth Rate
Figure Global Rare Disease Treatment Market Size in Retail Pharmacies Growth Rate
Table Global Rare Disease Treatment Revenue by Players (2016-2018) ($ Millions)
Table Global Rare Disease Treatment Revenue Market Share by Players (2016-2018)
Figure Global Rare Disease Treatment Revenue Market Share by Players in 2017
Table Global Rare Disease Treatment Key Players Head office and Products Offered
Table Rare Disease Treatment Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Rare Disease Treatment Market Size by Regions 2013-2018 ($ Millions)
Table Global Rare Disease Treatment Market Size Market Share by Regions 2013-2018
Figure Global Rare Disease Treatment Market Size Market Share by Regions 2013-2018
Figure Americas Rare Disease Treatment Market Size 2013-2018 ($ Millions)
Figure APAC Rare Disease Treatment Market Size 2013-2018 ($ Millions)
Figure Europe Rare Disease Treatment Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Rare Disease Treatment Market Size 2013-2018 ($ Millions)
Table Americas Rare Disease Treatment Market Size by Countries (2013-2018) ($ Millions)
Table Americas Rare Disease Treatment Market Size Market Share by Countries (2013-2018)
Figure Americas Rare Disease Treatment Market Size Market Share by Countries in 2017
Table Americas Rare Disease Treatment Market Size by Type (2013-2018) ($ Millions)
Table Americas Rare Disease Treatment Market Size Market Share by Type (2013-2018)
Figure Americas Rare Disease Treatment Market Size Market Share by Type in 2017
Table Americas Rare Disease Treatment Market Size by Application (2013-2018) ($ Millions)
Table Americas Rare Disease Treatment Market Size Market Share by Application (2013-2018)
Figure Americas Rare Disease Treatment Market Size Market Share by Application in 2017
Figure United States Rare Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Canada Rare Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Rare Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Table APAC Rare Disease Treatment Market Size by Countries (2013-2018) ($ Millions)
Table APAC Rare Disease Treatment Market Size Market Share by Countries (2013-2018)
Figure APAC Rare Disease Treatment Market Size Market Share by Countries in 2017
Table APAC Rare Disease Treatment Market Size by Type (2013-2018) ($ Millions)
Table APAC Rare Disease Treatment Market Size Market Share by Type (2013-2018)
Figure APAC Rare Disease Treatment Market Size Market Share by Type in 2017
Table APAC Rare Disease Treatment Market Size by Application (2013-2018) ($ Millions)
Table APAC Rare Disease Treatment Market Size Market Share by Application (2013-2018)
Figure APAC Rare Disease Treatment Market Size Market Share by Application in 2017
Figure China Rare Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Japan Rare Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Korea Rare Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Rare Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure India Rare Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Australia Rare Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Table Europe Rare Disease Treatment Market Size by Countries (2013-2018) ($ Millions)
Table Europe Rare Disease Treatment Market Size Market Share by Countries (2013-2018)
Figure Europe Rare Disease Treatment Market Size Market Share by Countries in 2017
Table Europe Rare Disease Treatment Market Size by Type (2013-2018) ($ Millions)
Table Europe Rare Disease Treatment Market Size Market Share by Type (2013-2018)
Figure Europe Rare Disease Treatment Market Size Market Share by Type in 2017
Table Europe Rare Disease Treatment Market Size by Application (2013-2018) ($ Millions)
Table Europe Rare Disease Treatment Market Size Market Share by Application (2013-2018)
Figure Europe Rare Disease Treatment Market Size Market Share by Application in 2017
Figure Germany Rare Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure France Rare Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure UK Rare Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Italy Rare Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Russia Rare Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Spain Rare Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Rare Disease Treatment Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Rare Disease Treatment Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Rare Disease Treatment Market Size Market Share by Countries in 2017
Table Middle East & Africa Rare Disease Treatment Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Rare Disease Treatment Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Rare Disease Treatment Market Size Market Share by Type in 2017
Table Middle East & Africa Rare Disease Treatment Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Rare Disease Treatment Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Rare Disease Treatment Market Size Market Share by Application in 2017
Figure Egypt Rare Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Rare Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Israel Rare Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Rare Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Rare Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Global Rare Disease Treatment arket Size Forecast (2018-2023) ($ Millions)
Table Global Rare Disease Treatment Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Rare Disease Treatment Market Size Market Share Forecast by Regions
Figure Americas Rare Disease Treatment Market Size 2018-2023 ($ Millions)
Figure APAC Rare Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Europe Rare Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Rare Disease Treatment Market Size 2018-2023 ($ Millions)
Figure United States Rare Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Canada Rare Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Mexico Rare Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Brazil Rare Disease Treatment Market Size 2018-2023 ($ Millions)
Figure China Rare Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Japan Rare Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Korea Rare Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Rare Disease Treatment Market Size 2018-2023 ($ Millions)
Figure India Rare Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Australia Rare Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Germany Rare Disease Treatment Market Size 2018-2023 ($ Millions)
Figure France Rare Disease Treatment Market Size 2018-2023 ($ Millions)
Figure UK Rare Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Italy Rare Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Russia Rare Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Spain Rare Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Egypt Rare Disease Treatment Market Size 2018-2023 ($ Millions)
Figure South Africa Rare Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Israel Rare Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Turkey Rare Disease Treatment Market Size 2018-2023 ($ Millions)
Figure GCC Countries Rare Disease Treatment Market Size 2018-2023 ($ Millions)
Table Global Rare Disease Treatment Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Rare Disease Treatment Market Size Market Share Forecast by Type (2018-2023)
Table Global Rare Disease Treatment Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Rare Disease Treatment Market Size Market Share Forecast by Application (2018-2023)
Table Novartis Basic Information, Head Office, Major Market Areas and Its Competitors
Table Novartis Rare Disease Treatment Revenue and Gross Margin (2016-2018)
Figure Novartis Rare Disease Treatment Market Share (2016-2018)
Table Pfizer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Pfizer Rare Disease Treatment Revenue and Gross Margin (2016-2018)
Figure Pfizer Rare Disease Treatment Market Share (2016-2018)
Table F. Hoffmann-La Roche Basic Information, Head Office, Major Market Areas and Its Competitors
Table F. Hoffmann-La Roche Rare Disease Treatment Revenue and Gross Margin (2016-2018)
Figure F. Hoffmann-La Roche Rare Disease Treatment Market Share (2016-2018)
Table Celgene Basic Information, Head Office, Major Market Areas and Its Competitors
Table Celgene Rare Disease Treatment Revenue and Gross Margin (2016-2018)
Figure Celgene Rare Disease Treatment Market Share (2016-2018)
Table AbbVie Basic Information, Head Office, Major Market Areas and Its Competitors
Table AbbVie Rare Disease Treatment Revenue and Gross Margin (2016-2018)
Figure AbbVie Rare Disease Treatment Market Share (2016-2018)
Table Johnson & Johnson Basic Information, Head Office, Major Market Areas and Its Competitors
Table Johnson & Johnson Rare Disease Treatment Revenue and Gross Margin (2016-2018)
Figure Johnson & Johnson Rare Disease Treatment Market Share (2016-2018)
Table Shire Basic Information, Head Office, Major Market Areas and Its Competitors
Table Shire Rare Disease Treatment Revenue and Gross Margin (2016-2018)
Figure Shire Rare Disease Treatment Market Share (2016-2018)
Table Alexion Basic Information, Head Office, Major Market Areas and Its Competitors
Table Alexion Rare Disease Treatment Revenue and Gross Margin (2016-2018)
Figure Alexion Rare Disease Treatment Market Share (2016-2018)
Table Novo Nordisk Basic Information, Head Office, Major Market Areas and Its Competitors
Table Novo Nordisk Rare Disease Treatment Revenue and Gross Margin (2016-2018)
Figure Novo Nordisk Rare Disease Treatment Market Share (2016-2018)
Table Sanofi Basic Information, Head Office, Major Market Areas and Its Competitors
Table Sanofi Rare Disease Treatment Revenue and Gross Margin (2016-2018)
Figure Sanofi Rare Disease Treatment Market Share (2016-2018)
Table Bayer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Amgen Basic Information, Head Office, Major Market Areas and Its Competitors
Table Allergan Basic Information, Head Office, Major Market Areas and Its Competitors
Table Eisai Basic Information, Head Office, Major Market Areas and Its Competitors
Table Bristol-Myers Squibb Basic Information, Head Office, Major Market Areas and Its Competitors
Table Merck Basic Information, Head Office, Major Market Areas and Its Competitors
Table Vertex Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Baxter Basic Information, Head Office, Major Market Areas and Its Competitors
Table BioMarin Basic Information, Head Office, Major Market Areas and Its Competitors
Table Teva Pharmaceutical Industries Basic Information, Head Office, Major Market Areas and Its Competitors